Metagenomi Therapeutics Cash Flow Statement (2023-2026) | MGX

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -11.74M-13.01M-19.82M-19.29M-25.15M-10.74M-18.77M-23.40M-25.04M-19.91M-20.39M-22.53M-23.06M
Depreciation and Depletion (Quarter) 0.84M1.01M1.15M1.19M1.27M1.31M1.36M1.45M1.36M1.33M1.32M1.28M1.27M
Share-based Compensation (Quarter) 0.53M0.66M3.27M2.47M5.06M4.51M3.22M3.41M2.93M3.22M3.01M2.69M2.55M
Gains from Sales and Divestitures (Quarter) 0.11M0.25M0.02M0.50M0.01M0.09M0.25M0.31M0.02M
Gains from Investment Securities (Quarter) 30.61M0.23M0.06M0.06M0.06M0.06M0.11M1.30M1.34M2.24M0.06M
Asset Writedowns and Impairment (Quarter) 0.01M0.00M0.28M0.01M0.75M0.18M
Non-cash Items (Quarter) 111.02M0.00M0.12M0.71M0.24M0.89M1.06M1.20M1.26M
Cash from Operations (Quarter) -21.00M-26.09M-23.73M-20.59M-29.85M-26.31M-26.64M-26.28M-22.84M-21.25M-21.25M-23.55M-21.18M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 2.15M2.38M2.32M1.62M1.22M1.98M1.63M1.34M1.01M0.82M0.70M0.47M0.36M
Depreciation & Amortization (CF) (Quarter) 0.84M1.01M1.15M1.19M1.27M1.31M1.36M1.45M1.36M1.33M1.32M1.28M1.27M
Change in Working Capital
Change in Receivables (Quarter) 1.60M-1.47M-0.37M-0.43M-1.06M0.67M-0.24M-0.14M0.09M-0.66M-0.30M
Change in Account Payables (Quarter) 1.21M-0.32M1.56M-2.52M3.16M-1.43M-0.27M-2.57M2.21M0.07M-1.58M0.35M0.80M
Change in Accured Expenses (Quarter) -1.30M1.38M0.66M0.90M-2.96M3.30M-0.92M-0.32M-2.65M0.17M4.02M-3.19M-2.03M
Change in Taxes (Quarter) 1.94M-0.76M-0.55M1.10M
Investing Activities
Capital Expenditures (Quarter) 2.67M-1.07M6.48M1.74M0.92M0.17M-0.82M2.84M0.29M-0.25M0.03M0.50M0.03M
Change in Acquisitions & Divestments (Quarter) 49.80M34.21M78.15M101.49M80.85M62.13M37.18M41.22M47.30M37.67M33.50M52.00M40.76M
Cash from Investing Activities (Quarter) -72.07M-18.72M75.89M60.63M-94.73M-13.04M-8.93M28.55M24.73M19.07M27.36M32.37M3.99M
Financing Activities
Other financing activities (Quarter) 0.08M0.28M0.19M0.02M0.03M
Change in Capital Stock
Shares Issued (Quarter) 86.54M-2.03M-0.49M0.11M
Preferred Shares Issued (Quarter) 4.29M
Misc.
Cash from Financing Activities (Quarter) 4.29M-0.04M-1.91M-1.33M86.54M-2.03M-0.49M-0.08M-0.17M-0.19M0.07M-0.03M
Change in Cash (Quarter) -88.77M-44.85M50.25M38.71M-38.05M-41.38M-36.06M2.27M1.81M-2.35M5.92M8.89M-17.22M
Free Cash Flow (Quarter) -23.66M-25.02M-30.21M-22.33M-30.77M-26.48M-25.82M-29.12M-23.13M-21.00M-21.28M-24.05M-21.20M
Net Cash Flow (Quarter) -88.77M-44.85M50.25M38.71M-38.05M-41.38M-36.06M2.27M1.81M-2.35M5.92M8.89M-17.22M